×

Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS

Zenas Biopharma has acquired global rights to develop the BTK inhibitor orelabrutinib to treat multiple sclerosis (MS) and other diseases. The deal with orelabrutinib’s developer, Innocare Pharma, includes rights to […] The post Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS appeared…

Dropping antibody levels

Tweet Two treatments that block vaccine responses are fingolimod and anti CD20 antibodies. They also block circulating antibodies and this can be a biomarker for infection. Here they say antibody IgG don’t drop after a switch from fingo to ocrelizumab or rituximab. However they look …

Making the Most of Life After an MS Diagnosis

By Dr. Eva Jackson Reflections on Life After Diagnosis Over the past several years, I have had the privilege of hearing MS Warriors share their personal experiences following their diagnosis of multiple sclerosis. Their stories offer a unique perspective on … Continue reading → Source:…

‘The Multiple Sclerosis Fashionista’ champions adaptive fashion

Roxy Murray was living up to being known as “The Multiple Sclerosis Fashionista” when she attended the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in […] The post ‘The Multiple Sclerosis Fashionista’ champions adaptive fashion appeared first on Multiple Sclerosis…

Aging and Repair

Tweet Aging and Repair is a time old question and no doubt as I grow older I am falling to bits.However can you repair your brain? Interms of myelin repair we know the answer can be yes but it was evident that some regions repair…

Menopause doesn’t worsen multiple sclerosis disability progression

Disability progression does not seem to worsen in women with multiple sclerosis (MS) after they undergo menopause, according to the largest study of its kind. Instead, other factors such as […] The post Menopause doesn’t worsen multiple sclerosis disability progression appeared first on Multiple Sclerosis…